| MRI-targeted or standard biopsy for prostate-cancer diagnosis V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ... New England Journal of Medicine 378 (19), 1767-1777, 2018 | 3644 | 2018 |
| Automatic multi-organ segmentation on abdominal CT with dense V-networks E Gibson, F Giganti, Y Hu, E Bonmati, S Bandula, K Gurusamy, ... IEEE transactions on medical imaging 37 (8), 1822-1834, 2018 | 870 | 2018 |
| Multiparametric MRI for prostate cancer diagnosis: current status and future directions A Stabile, F Giganti, AB Rosenkrantz, SS Taneja, G Villeirs, IS Gill, C Allen, ... Nature reviews urology 17 (1), 41-61, 2020 | 471 | 2020 |
| Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study D Dong, MJ Fang, L Tang, XH Shan, JB Gao, F Giganti, RP Wang, X Chen, ... Annals of oncology 31 (7), 912-920, 2020 | 403 | 2020 |
| Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review IG Schoots, N Petrides, F Giganti, LP Bokhorst, A Rannikko, L Klotz, ... European urology 67 (4), 627-636, 2015 | 393 | 2015 |
| Prostate imaging quality (PI-QUAL): a new quality control scoring system for multiparametric magnetic resonance imaging of the prostate from the PRECISION trial F Giganti, C Allen, M Emberton, CM Moore, V Kasivisvanathan, ... European urology oncology 3 (5), 615-619, 2020 | 329 | 2020 |
| ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation … M de Rooij, B Israël, M Tummers, HU Ahmed, T Barrett, F Giganti, ... European radiology 30 (10), 5404-5416, 2020 | 319 | 2020 |
| Reporting magnetic resonance imaging in men on active surveillance for prostate cancer: the PRECISE recommendations—a report of a European School of Oncology Task Force CM Moore, F Giganti, P Albertsen, C Allen, C Bangma, A Briganti, ... European urology 71 (4), 648-655, 2017 | 285 | 2017 |
| Magnetic resonance imaging-targeted biopsy versus systematic biopsy in the detection of prostate cancer: a systematic review and meta-analysis V Kasivisvanathan, A Stabile, JB Neves, F Giganti, M Valerio, ... European urology 76 (3), 284-303, 2019 | 257 | 2019 |
| Five-year outcomes of magnetic resonance imaging–based active surveillance for prostate cancer: a large cohort study V Stavrinides, F Giganti, B Trock, S Punwani, C Allen, A Kirkham, ... European urology 78 (3), 443-451, 2020 | 172 | 2020 |
| National implementation of multi‐parametric magnetic resonance imaging for prostate cancer detection–recommendations from a UK consensus meeting M Brizmohun Appayya, J Adshead, HU Ahmed, C Allen, A Bainbridge, ... BJU international 122 (1), 13-25, 2018 | 159 | 2018 |
| Factors influencing variability in the performance of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer: a systematic literature review A Stabile, F Giganti, V Kasivisvanathan, G Giannarini, CM Moore, ... European urology oncology 3 (2), 145-167, 2020 | 154 | 2020 |
| Medium‐term oncological outcomes in a large cohort of men treated with either focal or hemi‐ablation using high‐intensity focused ultrasonography for primary localized prostate … A Stabile, C Orczyk, F Hosking‐Jervis, F Giganti, M Arya, RG Hindley, ... BJU international 124 (3), 431-440, 2019 | 148 | 2019 |
| Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology F De Cobelli, F Giganti, E Orsenigo, M Cellina, A Esposito, G Agostini, ... European radiology 23 (8), 2165-2174, 2013 | 135 | 2013 |
| Gastric cancer: texture analysis from multidetector computed tomography as a potential preoperative prognostic biomarker F Giganti, S Antunes, A Salerno, A Ambrosi, P Marra, R Nicoletti, ... European radiology 27 (5), 1831-1839, 2017 | 129 | 2017 |
| An update of pitfalls in prostate mpMRI: a practical approach through the lens of PI-RADS v. 2 guidelines V Panebianco, F Giganti, YX Kitzing, F Cornud, R Campa, G De Rubeis, ... Insights into imaging 9 (1), 87-101, 2018 | 116 | 2018 |
| VERDICT MRI for prostate cancer: intracellular volume fraction versus apparent diffusion coefficient EW Johnston, E Bonet-Carne, U Ferizi, B Yvernault, H Pye, D Patel, ... Radiology 291 (2), 391-397, 2019 | 112 | 2019 |
| PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI M de Rooij, C Allen, JJ Twilt, LCP Thijssen, P Asbach, T Barrett, ... European radiology 34 (11), 7068-7079, 2024 | 109 | 2024 |
| Apparent diffusion coefficient value and ratio as noninvasive potential biomarkers to predict prostate cancer grading: comparison with prostate biopsy and radical prostatectomy … F De Cobelli, S Ravelli, A Esposito, F Giganti, A Gallina, F Montorsi, ... American Journal of Roentgenology 204 (3), 550-557, 2015 | 107 | 2015 |
| Is magnetic resonance imaging‐targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low‐risk prostate cancer? A systematic … IG Schoots, D Nieboer, F Giganti, CM Moore, CH Bangma, MJ Roobol BJU international 122 (6), 946-958, 2018 | 105 | 2018 |
